glp 1 fda ban is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Fmr. FDA Commissioner weighs in

Molecular communications in the gutbrain axis, between the central nervous system and the gastrointestinal tract, are critical for maintaining healthy brain function, particularly in aging

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.

Pakistans healthcare landscape has entered a pivotal phase in the management of diabetes and obesity

The rise in GLP-1 adoption will put further pressure on CPG brands to adjust global portfolios to meet the shifting taste, functional health & dietary preferences

Automated point-of-sale diagnosis verification for GLP-1 RAs reduces costs and improves access versus traditional prior authorization.